Plus   Neg

Stock Alert: E.l.f Beauty Rises 10% On Upbeat Q4 Results

Shares of e.l.f. Beauty, Inc. (ELF) are gaining more than 10 percent or $1.49 in Friday's morning trade at $15.92 after the beauty company reported earnings and sales for the fourth quarter that beat analysts' expectations.

Thursday, e.l.f. Beauty said its fourth-quarter net loss was $0.3 million or $0.01 per share, narrower than $17.9 million or $0.37 per share loss in the year-ago quarter. Adjusted earnings for the quarter were $0.10 per share, compared to $0.06 per share in the prior-year quarter. Net sales grew 13 percent to $74.7 million from $66.1 million in the same period last year.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.05 per share for the quarter on sales of $67.06 million. Analysts' estimates typically exclude special items. e.l.f. Beauty said it has been a significant decline in retail sales due to the impact of the COVID-19 pandemic and expects this trend to continue until consumers return to normal shopping pattern.

The stock has traded in a range of $7.58 to $20.00 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT